Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II feasibility study of pre-operative doxycycline in early-stage breast cancer
2016-000871-26Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of doxycycline in breast cancer (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Ki67 evaluation. Started Jun 2021; status: completed.
02
Drugs
doxycycline
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-000871-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000871-26.